{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:55:18Z","timestamp":1782863718630,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019084","name":"Kobe University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019084","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Prediction and early diagnosis are critical for the effective treatment of sinusoidal obstruction syndrome\/veno-occlusive disease (SOS\/VOD) after hematopoietic stem cell transplantation (HSCT). This study aimed to investigate the utility of clinical hepatic indices easily calculated in routine practice, namely the Endothelial Activation and Stress Index (EASIX), aspartate aminotransferase-to-platelet ratio index (APRI), Fibrosis-4 (FIB-4), reversed Albumin-Bilirubin grade (rALBI), Model for End-Stage Liver Disease (MELD), and MELD score and the serum sodium concentration (MELDNa). We retrospectively analyzed longitudinal clinical data from 175 allogeneic HSCTs at our institution. The 22 patients who eventually developed clinical SOS\/VOD were used as the reference standard. At baseline, EASIX, APRI, FIB-4, rALBI, MELD, and MELDNa were analyzed using the receiver operating characteristic method, with resulting area under the curve (95% confidence interval) of 0.739 (0.607\u20130.871), 0.770 (0.641\u20130.898), 0.760 (0.645\u20130.875), 0.672 (0.530\u20130.815), 0.577 (0.440\u20130.713), and 0.642 (0.449\u20130.784), respectively. After HSCT, these indices were also associated with SOS\/VOD, even 7\u00a0days before diagnosis (all\n                    <jats:italic>p<\/jats:italic>\n                    -values\u2009&lt;\u20090.001). In conclusion, clinical hepatic indices are useful for prediction and early diagnosis of SOS\/VOD in allogeneic HSCT recipients. Further studies are required to determine their optimal clinical application.\n                  <\/jats:p>","DOI":"10.1007\/s12185-026-04191-5","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:47:09Z","timestamp":1773694029000},"page":"114-125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical hepatic indices serve as predictive markers for sinusoidal obstruction syndrome after allogeneic HSCT"],"prefix":"10.1007","volume":"124","author":[{"given":"Hiroya","family":"Ichikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-7857","authenticated-orcid":false,"given":"Kimikazu","family":"Yakushijin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Inui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakura","family":"Kamido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Harima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Okazoe-Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakuya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Kitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"3","key":"4191_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/bmt.2015.283","volume":"51","author":"K Yakushijin","year":"2016","unstructured":"Yakushijin K, Atsuta Y, Doki N, Yokota A, Kanamori H, Miyamoto T, et al. Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Bone Marrow Transpl. 2016;51(3):403\u20139.","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"4191_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41409-022-01900-6","volume":"58","author":"M Mohty","year":"2023","unstructured":"Mohty M, Blaise D, Peffault de Latour R, Labopin M, Bourhis JH, Bruno B, et al. Real-world use of defibrotide for veno-occlusive disease\/sinusoidal obstruction syndrome: the DEFIFrance registry study. Bone Marrow Transpl. 2023;58(4):367\u201376.","journal-title":"Bone Marrow Transpl"},{"issue":"11","key":"4191_CR3","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s41409-023-02077-2","volume":"58","author":"T Ruutu","year":"2023","unstructured":"Ruutu T, Peczynski C, Houhou M, Polge E, Mohty M, Kroger N, et al. Current incidence, severity, and management of veno-occlusive disease\/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT transplant complications working party study. Bone Marrow Transpl. 2023;58(11):1209\u201314.","journal-title":"Bone Marrow Transpl"},{"issue":"13","key":"4191_CR4","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","volume":"127","author":"PG Richardson","year":"2016","unstructured":"Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Termuhlen AM, et al. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood. 2016;127(13):1656\u201365.","journal-title":"Blood"},{"issue":"2","key":"4191_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","volume":"33","author":"S Corbacioglu","year":"2004","unstructured":"Corbacioglu S, Greil J, Peters C, Wulffraat N, Laws HJ, Dilloo D, et al. Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transpl. 2004;33(2):189\u201395.","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"4191_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/bjh.14727","volume":"178","author":"PG Richardson","year":"2017","unstructured":"Richardson PG, Smith AR, Triplett BM, Kernan NA, Grupp SA, Antin JH, et al. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease\/sinusoidal obstruction syndrome improves day +100 survival following haematopoietic stem cell transplantation. Br J Haematol. 2017;178(1):112\u20138.","journal-title":"Br J Haematol"},{"issue":"7","key":"4191_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41409-023-01992-8","volume":"58","author":"M Mohty","year":"2023","unstructured":"Mohty M, Malard F, Alaskar AS, Aljurf M, Arat M, Bader P, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). Bone Marrow Transpl. 2023;58(7):749\u201354.","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"4191_CR8","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41409-024-02215-4","volume":"59","author":"H Ichikawa","year":"2024","unstructured":"Ichikawa H, Yakushijin K, Kurata K, Tsuji T, Takemoto N, Joyce M, et al. Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome\/veno-occlusive disease. Bone Marrow Transpl. 2024;59(4):518\u201325.","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"4191_CR9","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1016\/S2352-3026(17)30108-4","volume":"4","author":"T Luft","year":"2017","unstructured":"Luft T, Benner A, Jodele S, Dandoy CE, Storb R, Gooley T, et al. EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis. Lancet Haematol. 2017;4(9):e414\u201323.","journal-title":"Lancet Haematol"},{"issue":"22","key":"4191_CR10","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1182\/bloodadvances.2022007381","volume":"6","author":"MT Nawas","year":"2022","unstructured":"Nawas MT, Sanchez-Escamilla M, Devlin SM, Maloy MA, Ruiz JD, Sauter CS, et al. Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation. Blood Adv. 2022;6(22):5898\u2013907.","journal-title":"Blood Adv"},{"issue":"10","key":"4191_CR11","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1038\/s41409-021-01390-y","volume":"56","author":"T Luft","year":"2021","unstructured":"Luft T, Dreger P, Radujkovic A. Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation. Bone Marrow Transpl. 2021;56(10):2326\u201335.","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"4191_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3324\/haematol.2019.238790","volume":"106","author":"S Jiang","year":"2021","unstructured":"Jiang S, Penack O, Terzer T, Schult D, Majer-Lauterbach J, Radujkovic A, et al. Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel. Haematologica. 2021;106(2):446\u201353.","journal-title":"Haematologica"},{"issue":"3","key":"4191_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41409-024-02489-8","volume":"60","author":"E Muratore","year":"2025","unstructured":"Muratore E, Gambuti G, Leardini D, Baccelli F, Venturelli F, Larcinese L, et al. The EASIX score as a predictor of sinusoidal obstruction syndrome and nonrelapse mortality in paediatric patients receiving allogeneic haematopoietic stem cell transplantation. Bone Marrow Transpl. 2025;60(3):346\u201352.","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"4191_CR14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518\u201326.","journal-title":"Hepatology"},{"issue":"6","key":"4191_CR15","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","journal-title":"Hepatology"},{"issue":"6","key":"4191_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550\u20138.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4191_CR17","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1053\/he.2000.5852","volume":"31","author":"M Malinchoc","year":"2000","unstructured":"Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864\u201371.","journal-title":"Hepatology"},{"issue":"9","key":"4191_CR18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/jlts.2002.35927","volume":"8","author":"RB Freeman Jr","year":"2002","unstructured":"Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002;8(9):851\u20138.","journal-title":"Liver Transpl"},{"issue":"10","key":"4191_CR19","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","volume":"359","author":"WR Kim","year":"2008","unstructured":"Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359(10):1018\u201326.","journal-title":"N Engl J Med"},{"issue":"3","key":"4191_CR20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transpl. 2009;15(3):367\u20139.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"4191_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12874-020-01007-w","volume":"20","author":"C Partlett","year":"2020","unstructured":"Partlett C, Hall NJ, Leaf A, Juszczak E, Linsell L. Application of the matched nested case-control design to the secondary analysis of trial data. BMC Med Res Methodol. 2020;20(1):117.","journal-title":"BMC Med Res Methodol"},{"issue":"9","key":"4191_CR22","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s00277-022-04886-9","volume":"101","author":"S Shiratori","year":"2022","unstructured":"Shiratori S, Okada K, Matsuoka S, Ito S, Sugita J, Teshima T. Serum levels of albumin and creatinine predict the outcome of sinusoidal obstruction syndrome after allogeneic HSCT. Ann Hematol. 2022;101(9):2117\u20138.","journal-title":"Ann Hematol"},{"key":"4191_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000541157","volume":"148","author":"T Konuma","year":"2024","unstructured":"Konuma T, Monna-Oiwa M, Kato S, Isobe M, Takahashi S, Nannya Y. Prognostic value of the pretransplant fibrosis-4 index on non-relapse and overall mortality following unrelated single-unit cord blood transplantation in adults. Acta Haematol. 2024;148:1\u201311.","journal-title":"Acta Haematol"},{"issue":"7","key":"4191_CR24","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/bmt.2016.130","volume":"51","author":"M Mohty","year":"2016","unstructured":"Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transpl. 2016;51(7):906\u201312.","journal-title":"Bone Marrow Transpl"},{"issue":"10","key":"4191_CR25","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1097\/01.tp.0000183288.67746.44","volume":"80","author":"M Pihusch","year":"2005","unstructured":"Pihusch M, Wegner H, Goehring P, Salat C, Pihusch V, Hiller E, et al. Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: a prospective analysis in 350 allogeneic hematopoietic stem cell recipients. Transplantation. 2005;80(10):1376\u201382.","journal-title":"Transplantation"},{"issue":"3","key":"4191_CR26","first-page":"166","volume":"29","author":"S Putta","year":"2023","unstructured":"Putta S, Young BA, Levine JE, Reshef R, Nakamura R, Strouse C, et al. Prognostic biomarkers for hepatic veno-occlusive disease\/sinusoidal obstruction syndrome in myeloablative allogeneic hematopoietic cell transplantation: results from the blood and marrow transplant clinical trials network 1202 study. Transpl Cell Ther. 2023;29(3):166.","journal-title":"Transpl Cell Ther"},{"issue":"5","key":"4191_CR27","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s00277-024-05685-0","volume":"103","author":"K Takemura","year":"2024","unstructured":"Takemura K, Nakamae M, Okamura H, Sakatoku K, Ido K, Makuuchi Y, et al. Autotaxin is a potential predictive marker for the development of veno-occlusive disease\/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation. Ann Hematol. 2024;103(5):1705\u201315.","journal-title":"Ann Hematol"},{"issue":"9","key":"4191_CR28","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.bbmt.2018.05.025","volume":"24","author":"M Nishida","year":"2018","unstructured":"Nishida M, Kahata K, Hayase E, Shigematsu A, Sato M, Kudo Y, et al. Novel ultrasonographic scoring system of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2018;24(9):1896\u2013900.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"4191_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12185-021-03137-3","volume":"114","author":"M Nishida","year":"2021","unstructured":"Nishida M, Sugita J, Takahashi S, Iwai T, Sato M, Kudo Y, et al. Refined ultrasonographic criteria for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Int J Hematol. 2021;114(1):94\u2013101.","journal-title":"Int J Hematol"},{"issue":"9","key":"4191_CR30","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.3324\/haematol.2019.245407","volume":"106","author":"PE Debureaux","year":"2021","unstructured":"Debureaux PE, Bourrier P, Rautou PE, Zagdanski AM, De Boutiny M, Pagliuca S, et al. Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantation. Haematologica. 2021;106(9):2374\u201383.","journal-title":"Haematologica"},{"issue":"2","key":"4191_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10396-023-01392-x","volume":"51","author":"Y Inoue","year":"2024","unstructured":"Inoue Y, Saitoh S, Denpo H, Yamaguchi K, Kubota K, Taya Y, et al. Utility of liver stiffness measurement in the diagnosis of sinusoidal obstruction syndrome\/veno-occlusive disease after hematopoietic stem cell transplantation. J Med Ultrason. 2024;51(2):311\u201321.","journal-title":"J Med Ultrason"},{"issue":"4","key":"4191_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med. 1993;118(4):255\u201367.","journal-title":"Ann Intern Med"},{"issue":"6","key":"4191_CR33","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1182\/blood.V67.6.1773.1773","volume":"67","author":"B Rio","year":"1986","unstructured":"Rio B, Andreu G, Nicod A, Arrago JP, Dutrillaux F, Samama M, et al. Thrombocytopenia in venocclusive disease after bone marrow transplantation or chemotherapy. Blood. 1986;67(6):1773\u20136.","journal-title":"Blood"},{"issue":"4","key":"4191_CR34","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/jgh.14004","volume":"33","author":"T Miyata","year":"2018","unstructured":"Miyata T, Tajima H, Hirata M, Nakanuma SI, Makino I, Hayashi H, et al. Phosphodiesterase III inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse\u2019s space. J Gastroenterol Hepatol. 2018;33(4):950\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"4191_CR35","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3904\/kjim.2021.082","volume":"36","author":"JH Yoon","year":"2021","unstructured":"Yoon JH, Choi CW, Won JH. Hepatic sinusoidal obstruction syndrome\/veno-occlusive disease after hematopoietic cell transplantation: historical and current considerations in Korea. Korean J Intern Med. 2021;36(6):1261\u201380.","journal-title":"Korean J Intern Med"},{"issue":"7","key":"4191_CR36","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1097\/MPH.0000000000002938","volume":"46","author":"F Consonni","year":"2024","unstructured":"Consonni F, Ciulli A, Cuzzubbo D, Frenos S, Sanvito MC, Tondo A, et al. Refractory thrombocytopenia is the earliest diagnostic criterion for Sinusoidal Obstruction Syndrome in children. J Pediatr Hematol Oncol. 2024;46(7):e501\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"4191_CR37","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.bbmt.2019.11.012","volume":"26","author":"MM Embaby","year":"2020","unstructured":"Embaby MM, Rangarajan HG, Abu-Arja R, Auletta JJ, Stanek J, Pai V, et al. Refractory thrombocytopenia is a valid early diagnostic criteria for Hepatic Veno-Occlusive Disease in children. Biol Blood Marrow Transplant. 2020;26(3):546\u201352.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"4191_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/bmt.2017.161","volume":"53","author":"S Corbacioglu","year":"2018","unstructured":"Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle JH, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the european society for blood and marrow transplantation. Bone Marrow Transpl. 2018;53(2):138\u201345.","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"4191_CR39","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/bjh.16557","volume":"190","author":"MS Cairo","year":"2020","unstructured":"Cairo MS, Cooke KR, Lazarus HM, Chao N. Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS\/VOD after haematopoietic cell transplantation. Br J Haematol. 2020;190(6):822\u201336.","journal-title":"Br J Haematol"},{"issue":"3","key":"4191_CR40","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/jha2.728","volume":"4","author":"H Ichikawa","year":"2023","unstructured":"Ichikawa H, Yakushijin K, Miyata Y, Kanehira H, Joyce M, Hirakawa Y, et al. Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopenia. EJHaem. 2023;4(3):695\u2013704.","journal-title":"EJHaem"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04191-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04191-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04191-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:11:30Z","timestamp":1782861090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04191-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4191"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04191-5","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HI has received honoraria from Nippon Shinyaku. KYak has received honoraria from Nippon Shinyaku, Jazz Pharmaceuticals, Pfizer, Otsuka Pharmaceutical, and Asahi Kasei Pharma. AK has received honoraria from Nippon Shinyaku and Otsuka Pharmaceutical. TM has received honoraria from Nippon Shinyaku and Otsuka Pharmaceutical. HMa has received honoraria from Nippon Shinyaku, Pfizer, and Otsuka Pharmaceutical. HMi has received research funding from Nippon Shinyaku, Otsuka Pharmaceutical, and Asahi Kasei Pharma. The remaining authors declare no conflicts of interest. KYak was one of the lead reviewers of the International Journal of Hematology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}